MGINX
Price
$10.23
Change
-$0.03 (-0.29%)
Updated
Nov 13 closing price
PBAKX
Price
$14.73
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

MGINX vs PBAKX

Header iconMGINX vs PBAKX Comparison
Open Charts MGINX vs PBAKXBanner chart's image
DWS Global Macro Inst
Price$10.23
Change-$0.03 (-0.29%)
VolumeN/A
CapitalizationN/A
BlackRock Tactical Opportunities K
Price$14.73
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
MGINX vs PBAKX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGINX vs. PBAKX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGINX is a StrongBuy and PBAKX is a Buy.

FUNDAMENTALS
Fundamentals
PBAKX has more cash in the bank: 2.23B vs. MGINX (176M). PBAKX pays higher dividends than MGINX: PBAKX (11.15) vs MGINX (1.75). MGINX was incepted earlier than PBAKX: MGINX (30 years) vs PBAKX (8 years). PBAKX is a more actively managed with annual turnover of: 172.00 vs. MGINX (48.00). MGINX has a lower initial minimum investment than PBAKX: MGINX (1000000) vs PBAKX (5000000). PBAKX (8.32) and MGINX (8.19) have marching annual gain over last year. PBAKX return over 5 years is better than : 25.66 vs. MGINX (15.13).
MGINXPBAKXMGINX / PBAKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years8 years-
Gain YTD4.24110.83539%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets176M2.23B8%
Annual Yield % from dividends1.7511.1516%
Returns for 1 year8.198.3298%
Returns for 3 years4.3418.8623%
Returns for 5 years15.1325.6659%
Returns for 10 years48.46N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TUSK3.510.05
+1.45%
Mammoth Energy Services
HAYN60.700.10
+0.17%
Haynes International
POOL350.94-4.34
-1.22%
Pool Corp
EVGN1.88-0.08
-4.08%
Evogene Ltd.
VRNA36.94-2.06
-5.28%
Verona Pharma plc